THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ADZYNMA tracked for safety in rare blood disorder
Disease control Recruiting nowThis study monitors 40 people in Japan with congenital thrombotic thrombocytopenic purpura (cTTP) who are receiving ADZYNMA (recombinant ADAMTS13) as part of their routine care. Researchers will track side effects and check if the drug improves platelet counts and ADAMTS13 activi…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New study tracks safety of adzynma for rare blood clot disorder
Knowledge-focused Recruiting nowThis study looks at the real-world safety of Adzynma, a lab-made protein, in people with congenital thrombotic thrombocytopenic purpura (cTTP), a rare inherited blood disorder. Researchers will review medical records of about 50 children and adults to see how many develop allergi…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists hunt for relapse clues in TTP Patients' immune cells
Knowledge-focused Recruiting nowThis study looks at blood samples from 44 people with thrombotic thrombocytopenic purpura (TTP) to understand how certain immune cells (B and T lymphocytes) react to the ADAMTS13 protein during different stages of the disease. The goal is to find early warning signs that could pr…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Massive study aims to unlock secrets of rare blood disorder
Knowledge-focused Recruiting nowThis study reviews medical records from over 1,200 people with immune thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood disorder. The goal is to understand long-term health problems, such as heart disease and thinking issues, that survivors face. By an…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC